ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

NUTX // Nutex Health Inc.

ANR <GO> NASDAQ RQD COCKPIT → CIK 0001479681 ↗
Consumer Discretionary • Business Services
$210.10 ▼ -2.53 (-1.19%)
MKT CAP: $1.44B • VOL: 79.6K
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8 SELL: 2
12M STREET TARGET RANGE IMPLIED: +14.0%
LOW
$176
MEDIAN
$235
MEAN
$240
HIGH
$286
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100 EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE NUTX TAPE
NUTX // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>) CURRENT 90D STREET CONSENSUS
INSTITUTION / ANALYST ACTION RATING TARGET PRIOR PT CALL DATE PX AT CALL RET SINCE CALL 1Y ACCURACY BS GRADE
Morgan Stanley Institutional
Equity Desk
REITERATE OUTPERFORM $254.22 $241.61 2025-02-14 $191.19 +9.9% 78% A
Goldman Sachs Global Research
Sector Coverage
TARGET REV STRONG BUY $264.73 $247.92 2025-02-06 $197.49 +6.4% 74% A
J.P. Morgan Securities
US Large Cap
REITERATE BUY $239.51 $231.11 2025-01-29 $201.70 +4.2% 67% B
Bernstein Autonomous
Forensic Coverage
INITIATE HOLD $214.30 — 2025-01-17 $205.90 +2.0% 61% B
Barclays Capital
Americas Research
DOWNGRADE UNDERPERFORM $184.89 $199.59 2025-01-09 $186.99 -11.2% 42% D
UBS Investment Bank
Institutional Desk
UPGRADE BUY $250.02 $218.50 2024-12-18 $182.79 +14.9% 72% A
Citigroup Global Markets
Sector Lead
TARGET REV HOLD $203.80 $212.20 2024-12-04 $195.39 -4.3% 48% C